NCT07542028 Comparison of the Analgesic Effects of TFPB in Renal Transplantation Surgery
| NCT ID | NCT07542028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Renal Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-04-27 |
| Primary Completion | 2027-10-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-04-27 with a primary completion date of 2027-10-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Renal transplantation is a major surgical procedure associated with significant postoperative pain, particularly due to lower abdominal incision, deep tissue dissection, and extensive surgical manipulation. Effective postoperative pain control is therefore of great importance in this patient population, as inadequate analgesia may impair early mobilization, delay recovery, increase opioid consumption, and contribute to opioid-related adverse effects. In addition, optimal analgesic management may improve patient comfort and support enhanced postoperative outcomes. Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications. In this study; it was aimed to compare the analgesic effectiveness of transversalis fascia plane block in the postoperative period in patients who underwent renal transplantation.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-65 years * American Society of Anesthesiologists (ASA) score III * Body Mass Index (BMI) between 18-30 kg/m2 Exclusion Criteria: * Patients under 18 and over 65 years of age * Patients with an ASA score other than III * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07542028 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Renal Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07542028 currently recruiting?
Yes, NCT07542028 is actively recruiting participants. Contact the research team at kansezgi@gmail.com for enrollment information.
Where is the NCT07542028 trial being conducted?
This trial is being conducted at Altındağ, Turkey (Türkiye).
Who is sponsoring the NCT07542028 clinical trial?
NCT07542028 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 50 participants.